FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Mono Pharmacare IPO and Saroja Pharma Industries IPO.
Mono Pharmacare IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Saroja Pharma Industries IPO is a SME Fixed Price Issue proposed to list at NSE SME.
Mono Pharmacare IPO | Saroja Pharma Industries IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Fixed Price Issue |
Listing At | NSE SME | NSE SME |
Lead Managers | Unistone Capital Pvt Ltd | Swastika Investmart Ltd |
Registrar | Bigshare Services Pvt Ltd | Kfin Technologies Limited |
Market Maker | Rikhav Securities Limited | Swastika Investmart Limited |
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Mono Pharmacare IPO is up to ₹14.84 Cr whereas the issue size of the Saroja Pharma Industries IPO is up to ₹9.11 Cr. The final issue price of Mono Pharmacare IPO is ₹28.00 per share and of Saroja Pharma Industries IPO is ₹84.00 per share.
Mono Pharmacare IPO | Saroja Pharma Industries IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ₹26.00 per share | |
Issue Price (Upper) | ₹28.00 per share | |
Issue Price (Final) | ₹28.00 per share | ₹84.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 4000 shares | 1600 shares |
Fresh Issue Size | 53,00,000 shares | 10,84,800 shares |
Fresh Issue Size (Amount) | up to ₹14.84 Cr | up to ₹9.11 Cr |
OFS Issue Size | ||
OFS Issue Size (Amount) | ||
Issue Size Total | 53,00,000 shares | 10,84,800 shares |
Issue Size Total (Amount) | up to ₹14.84 Cr | up to ₹9.11 Cr |
Mono Pharmacare IPO opens on Aug 28, 2023, while Saroja Pharma Industries IPO opens on Aug 31, 2023. The closing date of Mono Pharmacare IPO and Saroja Pharma Industries IPO is Aug 30, 2023, and Sep 05, 2023, respectively.
Mono Pharmacare IPO | Saroja Pharma Industries IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Aug 28, 2023 | Aug 31, 2023 |
Issue Close | Aug 30, 2023 | Sep 05, 2023 |
Basis Of Allotment (Tentative) | Sep 04, 2023 | Sep 08, 2023 |
Initiation of Refunds (Tentative) | Sep 05, 2023 | Sep 11, 2023 |
Credit of Share (Tentative) | Sep 06, 2023 | Sep 12, 2023 |
Listing date (Tentative) | Sep 07, 2023 | Sep 13, 2023 |
Anchor Lockin End date 1 | Oct 04, 2023 | Oct 08, 2023 |
Anchor Lockin End date 2 | Dec 03, 2023 | Dec 07, 2023 |
Mono Pharmacare IPO P/E ratio is , as compared to Saroja Pharma Industries IPO P/E ratio of 23.27.
Mono Pharmacare IPO | Saroja Pharma Industries IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
Amount in ₹ Lakhs |
Amount in ₹ Lakhs |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 81.02% | 100.00% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 73.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | 23.27 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ₹49.47 Cr. | ₹33.77 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 9.01%% | 0.15%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 10.34%% | 0.25%% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 2.92 | 2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹1.99 | ₹3.61 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 9.01%% | 20.85%% |
In the Mono Pharmacare IPO retail investors (RII) are offered 22,64,000 shares while in Saroja Pharma Industries IPO retail investors are offered 22,64,000 shares. Qualified institutional buyers (QIB) are offered 5,00,000 shares in Mono Pharmacare IPO and 0 shares in Saroja Pharma Industries IPO.
Mono Pharmacare IPO | Saroja Pharma Industries IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 2,76,000 shares | 54,400 shares |
QIB | 5,00,000 shares | 0 shares |
NII | 22,60,000 shares | 5,15,200 shares |
RII | 22,64,000 shares | 5,15,200 shares |
Employee | 0 shares | 0 shares |
Others | ||
Total | 50,24,000 shares | 10,30,400 shares |
Mono Pharmacare IPO subscribed 13.42x in total, whereas Saroja Pharma Industries IPO subscribed 8.88x.
Mono Pharmacare IPO | Saroja Pharma Industries IPO | |
---|---|---|
QIB (times) | 10.89x | |
NII (times) | 8.00x | 2.90x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 19.40x | 14.83x |
Employee (times) | ||
Other (times) | ||
Total (times) | 13.42x | 8.88x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|